Crawford & Co. Q1 2001 Financial Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2001. Crawford & Co. provides claims administration services through two reportable segments: Domestic Operations (U.S. branch offices) and International Operations (offices in 64 other countries). The company operates in the insurance and self-insured entity sectors, including class action services.
Key Financial Metrics
| Metric | Q1 2001 | Q1 2000 |
|---|---|---|
| Total Revenues | $179.5 million | $177.4 million |
| Net Income | $8.2 million | $10.5 million |
| Diluted EPS | $0.17 | $0.21 |
| Operating Income | $15.3 million | $18.7 million |
| Operating Margin | 8.5% | 10.6% |
| Cash from Operations | $10.0 million | $4.1 million |
| Cash & Equivalents | $23.3 million | $13.1 million |
| Short-term Debt | $47.9 million | $44.4 million |
| Long-term Debt | $36.5 million | $36.7 million |
Material Changes vs. Prior Period
- Profitability Decline: Net income decreased 22.3% year-over-year, driven by a 18.3% drop in operating income. Operating margins contracted from 10.6% to 8.5%.
- Revenue Mix: Total revenue grew 1.1%. Domestic revenue increased 2.4% (driven by insurance company partnerships and surveillance services), while International revenue fell 2.2% due to a strong U.S. dollar offsetting volume growth.
- Expense Pressure: Compensation and fringe benefits as a percentage of revenue increased to 62.8% (from 61.3%). Domestic compensation rose to 62.1% of revenue due to merit increases and higher self-insured medical costs. International compensation rose to 64.9% of revenue.
- Cash Flow: Operating cash flow more than doubled to $10.0 million, despite lower net income, due to favorable changes in working capital (specifically accounts receivable and taxes).
- Capital Allocation: The company suspended stock repurchases in Q1 2001 (compared to $25.3 million in buybacks in Q1 2000) but maintained dividend payments.
Outlook, Risks, and Contingencies
- Guidance: Management states Q1 results are not necessarily indicative of full-year results. Several major class action projects awarded recently are expected to contribute to revenue in the next two quarters.
- Regulatory Investigation: The company received federal grand jury subpoenas regarding billing practices in Domestic Claims Management and Healthcare Management Services dating back to 1992. The company is cooperating, but the financial impact is currently indeterminable.
- Currency Risk: International operations (26.7% of revenue) are exposed to foreign exchange fluctuations. A hypothetical 10% strengthening of the U.S. dollar would reduce pretax income by approximately $0.3 million. The company does not hedge foreign currency exposure.
- Restructuring: $223,000 of restructuring reserves were utilized in Q1. Remaining reserves of $2.5 million are deemed adequate for lease terminations and employee separations, primarily in the U.K.
Investor Verification Checklist
- Verify the potential financial impact of the federal grand jury investigation into billing practices.
- Monitor the realization of revenue from newly awarded class action projects mentioned in management commentary.
- Track the trend in compensation costs as a percentage of revenue, which has risen in both domestic and international segments.
- Assess the impact of the strong U.S. dollar on future international revenue growth.
- Review the status of the share repurchase program, which remains paused with 705,863 shares remaining to be repurchased.